|
|
|
|
PRESS RELEASE |
||
|
|
MedChannels Develops eJournalTM for Electronic Patient Reported OutcomesLAS VEGAS, NV, Jan. 04, 2007 /PRNewswire-FirstCall/ -- MedChannels, a state of Ohio limited liability corporation, has launched its highly-touted and long-anticipated eJournal platform for Patient Reported Outcomes. eJournal features the most innovative product line in the ePRO market today. Our choice of technologies, unique data transmission and successful experience guarantees you the best available solution to meet your specific study needs. From pilot studies to multinational clinical trials, you will find an answer to fit your budget and your timelines. MedChannels solutions are unique in that they:· Help sponsors to support labeling claims: MedChannels solutions provide sponsors with trust-worthy data that can be used reliably in new drug applications. · Provide more efficient trial management: Unlike other ePRO solutions on the market that are focused simply on collecting patient data, MedChannels solutions provide proactive patient and site management functionality, reduce the data management requirements of a given study, and are designed to support a quicker database lock. · Provide flexibility to accommodate study needs: MedChannels solutions help support shorter development timelines, allow for seamless mid-study changes with in-field updates and allow for thoughtful changes which may be required to meet evolving regulatory considerations. |
|
|
|
Physicians interested in participating in this unique program can download a marketing flyer from eJournal.pdf . Alternatively, MedChannels can send hard copy sales and marketing information by emailing your request to: Mail eJournal brochures or calling Martin James at 614-730-1345. |
|
|
|
MedChannels is a leading provider of life science development and commercialization services and has regional distribution hubs in Columbus, Ohio and San Antonio, Texas with headquarters in Las Vegas, NV. Its principal activities are to provide integrated product development and commercial enrichment solutions to the pharmaceutical, biotechnology and medical device industries. The Group operates in three business segments, namely Product Development, Commercialization Services and the Informatics group. The Product Development group is primarily responsible for all phases of pre-clinical and clinical research. The Commercialization Services group is primarily responsible for sales force deployment and strategic marketing services including healthcare policy research and consulting services. The Informatics group is primarily responsible for providing market research solutions and strategic analyses to support healthcare decisions. |
|
|
|
* * * * * * * * * * * * * Statements in this release concerning expectations for the future are forward-looking statements. A variety of known and unknown risks, uncertainties and other factors could cause actual results, performance and expectations to differ materially from anticipated results, performance or expectations. These risks, uncertainties and other factors are discussed in the company's annual report and other documents filed from time to time with the appropriate regulatory agency. http://tbutton.prnewswire.com/prn/b1690X77317545 SOURCE: MedChannels, Inc. Web site: http: //www.medchannels.com CONTACT: John Davidson, Investor Relations of MedChannels, Inc., +1-614-730-1345 * * * * * * * * * * * * * |
|